All In Biotech

Drug Trial Radar · NCT03059940

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 630 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

630

Actual

Start

Jun 16, 2017

Primary completion

Jan 15, 2027

Study completion Jan 15, 2027

Sponsor

Lead sponsor
M.D. Anderson Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI); Pfizer
First posted
Feb 23, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical research study is to offer lung cancer screenings to smokers who want to change their smoking behaviors. All eligible participants will receive smoking cessation counseling and may be offered at least one form of smoking cessation drug. Different forms of counseling (the delivery of counseling and access to counseling) will be compared. This is an investigational study. Participants on this study will not be prescribed smoking drugs directly by the study staff. However, participants in this study may or may not receive smoking cessation drugs, depending on what the provider thinks is in the participants best interest. All smoking cessation drugs being used are FDA approved and commercially available. It is investigational to compare the different forms of counseling participants receive. Up to 1260 participants will be enrolled in this study. All will take part at MD Anderson.

Conditions

  • Smoking Cessation

Interventions

  • QuestionnairesBehavioral

    Questionnaires completed at baseline and at 6 weeks, 12 weeks, and 6 months after the CT scan.

  • Low Dose Computed Tomography ScanProcedure

    Participants have a CT scan of chest to look for signs of lung cancer.

  • Shared Decision Making + VideoOther

    Participants given shared decision making and discussion about screening with the LDCT provider. Participants watch a short video about lung cancer, CT scans, and smoking cessation.

  • Cessation CounselingBehavioral

    Brief cessation counseling given by LDCT provider.

  • QuitlineBehavioral

    Participants referred to the Quitline for counseling. Participants have 5 smoking cessation counseling sessions over the next 12 weeks.

  • Pharmacotherapy DiscussionBehavioral

    Participant informed of the risk, benefits and relative efficacy of cessation medications and to assess their medication preferences, expectations and medical suitability for either option. At the conclusion of this conversation the patient is provided with an initial supply of the medication jointly decided between provider and patient.

  • Nicotine PatchDrug

    Nicotine patch dispensed. Dosing at physician's discretion.

  • Anti-Smoking DrugDrug

    Varenicline or Buproprion prescribed by study doctor with directions of when and how much of anti-smoking drug that should be taken each time.

  • Tobacco Treatment ProgramBehavioral

    Participant referred to Tobacco Treatment Program (TTP). TTP provides 4-8 counseling sessions and pharmacotherapy over a 10-12 week period,

  • Carbon Monoxide (CO) Level TestOther

    Participant asked to blow air through a CO-measuring device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Smoking Abstinence RateTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.